Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Histone Methyltransferase

Items 1-10 of 47

Page
per page
  1. (S)-PFI-2 (hydrochloride)
    C4834 (S)-PFI-2 (hydrochloride)
    Summary: Negative control of (R)-PFI 2 hydrochloride
      ≤0.5 mg/mL
  2. MS049 (hydrochloride)
    C3776 MS049 (hydrochloride)
    Summary: PRMT4 and PRMT6 inhibitor
      ≤30 mg/mL
  3. MS023 (hydrochloride)
    C3503 MS023 (hydrochloride)
    Summary: type I PRMTs inhibitor
      ≤30 mg/mL
  4. (R)-PFI 2 hydrochloride
    B8210 (R)-PFI 2 hydrochloride
      ≥26.8 mg/mL
  5. CPI-1205
    B7819 CPI-1205
    Summary: EZH2 inhibitor
      Soluble in DMSO
  6. HLCL-61
    B7806 HLCL-61
    Summary: PRMT5 inhibitor
      ≥20.4 mg/mL
  7. UNC 0642
    B7757 UNC 0642
    Target: G9a|GLP
    Summary: G9a and GLP histone lysine methyltransferase inhibitor
      insoluble in H2O; ≥18.5 mg/mL
  8. C 21
    B7756 C 21
    Summary: Protein arginine methyltransferase 1 (PRMT1) inhibitor
      Soluble to 2 mg/mL
  9. TC-E 5003
    B7750 TC-E 5003
    Summary: PRMT1 inhibitor, potent
      insoluble in EtOH; insoluble in H2O; ≥49 mg/mL
  10. MS023
    B6183 MS023
     1 Citation
    Summary: type I PRMTs inhibitor
      ≥28.7 mg/mL

Items 1-10 of 47

Page
per page